Home › Sickle Cell Disease › Virginia › Arlington
Sickle Cell Disease clinical trials in Arlington, VA
4 studies for Sickle Cell Disease are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
RecruitingPhase 3
- Inova Health System, Fairfax · 11 mi away
Early Screening and Treatment of Heart Complication in Sickle Cell Disease
RecruitingPhase 2
- Inova Health Care Service, Falls Church · 4 mi away
- Inova Schar Cancer, Fairfax · 11 mi away
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
RecruitingPhase 2/3
- Inova Schar Cancer Institute, Fairfax · 11 mi away
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RecruitingPhase 1/2Healthy volunteers welcome
- Inova Schar Cancer Institute, Fairfax · 11 mi away
About Sickle Cell Disease
Sickle cell disease is a group of inherited disorders that affect your red blood cells. It can cause pain, anemia, and other problems. Learn about treatments.
More about Sickle Cell Disease on MedlinePlus
Sickle Cell Disease trials in other cities
- Atlanta, GA22 studies
- Washington, DC20 studies
- Memphis, TN18 studies
- Chicago, IL18 studies
- Philadelphia, PA15 studies
- Birmingham, AL14 studies
- New York City, NY13 studies
- St. Louis, MO12 studies
- Durham, NC10 studies
- Houston, TX10 studies
- Boston, MA10 studies
- Cincinnati, OH10 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)48 studies
- Ovarian Cancer46 studies
- Breast Cancer46 studies
- Lung Cancer40 studies
- Endometrial Cancer39 studies
- Pancreatic Cancer34 studies
- Head and Neck Squamous Cell Carcinoma26 studies
- Small Cell Lung Cancer23 studies
- Melanoma20 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.